S343-0655 Screening compound: 4-[5-(1-ethyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-1-(4-methylphenyl)-2-pyrrolidinone

S343-0655 Screening compound: 4-[5-(1-ethyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-1-(4-methylphenyl)-2-pyrrolidinone
S343-0655 Screening compound: 4-[5-(1-ethyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-1-(4-methylphenyl)-2-pyrrolidinone alternative view

Chemical Structure Depiction of ChemDiv screening compound S343-0655
4-[5-(1-ethyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-1-(4-methylphenyl)-2-pyrrolidinone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S343-0655

Molecular Formula

C18H19N5O2 (C18 H19 N5 O2)

Compound Name

4-[5-(1-ethyl-1H-pyrazol-5-yl)-1,2,4-oxadiazol-3-yl]-1-(4-methylphenyl)-2-pyrrolidinone

IUPAC name

4-[5-(1-ethyl-1H-pyrazol-5-yl)-124-oxadiazol-3-yl]-1-(4-methylphenyl)pyrrolidin-2-one

SMILES

CCn1nccc1-c1nc(C(CC2=O)CN2c2ccc(C)cc2)no1

InChI

InChI=1S/C18H19N5O2/c1-3-23-15(8-9-19-23)18-20-17(21-25-18)13-10-16(24)22(11-13)14-6-4-12(2)5-7-14/h4-9,13H,3,10-11H2,1-2H3/t13-/m1/s1

InChI Key

TYMRVRNSRPGLFU-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD28999012

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

337.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.424

Distribution Coefficient, logD

2.424

Water Solubility, LogSw

-2.61

Polar Surface Area

61.483

Acid Dissociation Constant (pKa)

11.87

Base Dissociation Constant (pKb)

3.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.33

S343-0655 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S343-0655 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S343-0655?
Check Price and Availability of S343-0655, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S343-0655 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S343-0655
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S343-0655
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S343-0655 available by request